Could Biostage Incorporated (NASDAQ:BSTG) See a Reversal After More Sellers Came In?

September 17, 2017 - By Darrin Black

 Could Biostage Incorporated (NASDAQ:BSTG) See a Reversal After More Sellers Came In?

The stock of Biostage Incorporated (NASDAQ:BSTG) registered an increase of 10.26% in short interest. BSTG’s total short interest was 4.04M shares in September as published by FINRA. Its up 10.26% from 3.66 million shares, reported previously. With 1.89 million shares average volume, it will take short sellers 2 days to cover their BSTG’s short positions. The short interest to Biostage Incorporated’s float is 11.83%.

The stock increased 3.92% or $0.012 on September 15, reaching $0.329. About 1.33 million shares traded. Biostage Inc (NASDAQ:BSTG) has declined 78.72% since September 17, 2016 and is downtrending. It has underperformed by 95.42% the S&P500.

Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., is a biotechnology company. The company has market cap of $12.81 million. The Firm is engaged in developing bioengineered organ implants based on its Cellframe technology. It currently has negative earnings. The Company’s Cellframe technology consists of a biocompatible scaffold that is seeded with the recipient’s own cells.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.